352
Views
6
CrossRef citations to date
0
Altmetric
Letters to the Editor

Ponatinib for the treatment of Ph-like acute lymphoblastic leukemia

, , , , , , ORCID Icon, & ORCID Icon show all
Pages 755-757 | Received 06 Sep 2020, Accepted 20 Oct 2020, Published online: 05 Nov 2020
 

Disclosure statement

No conflict of interest to disclose.

Additional information

Funding

The authors wish to thank Associazione Italiana per la Ricerca sul Cancro (AIRC) 5×1000, Special Program Metastases (21198), Milan (Italy) to RF and GG; Finanziamento Medi Progetti Universitari 2015 (C26A15F9WW, Sapienza University of Rome) and 2018 (RM11816436B712AF, Sapienza University of Rome) to SC and PRIN 2017 (2017PPS2X4_002) to SC.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.